This Cancellation was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on August 12, 2022 and assigned serial number 92080331 by the TTAB.

Plaintiff:
FNC Medical Corporation represented by JEFF VANHOOSEAR of KNOBBE, MARTENS, OLSON & BEAR, LLP.
Trademark Information: DIABET-X – US Trademark Serial Number 75376992
View Trademark Status at USPTO
View Trademark Documents at USPTO

Defendant:
Aishita Aggarwal represented by REXFORD BRABSON, ESQ of T-REX LAW, P.C..
Trademark Information: DIABETEX – US Trademark Serial Number 90570355
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
August 12, 2022 – FILED AND FEE
August 12, 2022 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
August 12, 2022 – INSTITUTED
September 19, 2022 – D CHANGE OF CORRESP ADDRESS
September 19, 2022 – ANSWER
November 16, 2022 – P MOT FOR EXT W/ CONSENT
November 16, 2022 – EXTENSION OF TIME GRANTED
December 15, 2022 – P MOT FOR EXT W/ CONSENT
December 15, 2022 – EXTENSION OF TIME GRANTED
February 17, 2023 – P MOT FOR EXT W/ CONSENT
February 17, 2023 – EXTENSION OF TIME GRANTED
April 18, 2023 – P MOT FOR EXT W/ CONSENT
April 18, 2023 – EXTENSION OF TIME GRANTED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.